Transforming medical devices for improved patient outcomes

CLINICAL TRIALS

MiStent SES has received CE Mark in the European Union. The four-year follow-up for DESSOLVE I and II was completed in 2015, and patients continue to undergo long-term follow-up.

For more information on the specific publications associated with each of our clinical trials, please visit our News page.

map